FindTrial
Sign In

Role of Zinc in Sepsis

Role of Zinc in Sepsis: A Randomized, Double blinded, Placebo controlled trial

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013287
Enrollment
164
Registered
2018-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Sepsis

Interventions

Intervention1: Zinc: 1 Tablet(20 mg) PO OD for 14 days Control Intervention1: Placebo: 1tabet PO OD for 14 days

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children of 1 year to 15 years admitted to Paediatric ward/PICU in one year duration.

Exclusion criteria

Exclusion criteria: - Children without assent. - Children with immunocompromised state. - Children with inborn error of metabolism.

Design outcomes

Primary

MeasureTime frame
To evaluate the benefit of Zinc supplementation on mortality in children diagnosed as sepsis.Timepoint: 14 days—

Secondary

MeasureTime frame
To study effect of zinc supplementation on duration of hospital stay, need for higher antibiotics, need for inotropes, need for blood component and mechanical ventilation.Timepoint: 14 days—

Countries

Nepal

Contacts

Public ContactLalan Prasad Rauniyar

B.P. Koirala Institute of Health Sciences

gaurishankarshah@live.com9852062140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026